Drug-Induced Liver Injury by Selective Androgenic Receptor Modulators
Joan Ericka Flores, Shivakumar Chitturi, Sarah Walker
Hepatology communications 2020, 4 (3): 450-452
32140660
Selective androgenic receptor modulators (SARMs) have not been approved by the U.S. Food and Drug Administration but they are heavily promoted as alternatives to androgenic anabolic steroids. We present two cases of liver injury associated with SARMs.
Full Text Links
Find Full Text Links for this Article
You are not logged in. Sign Up or Log In to join the discussion.